The Gonorrhea Therapeutics Market Overview 2025 report reveals that the market size has grown significantly over the past few years, with projections indicating further expansion.
The global market size for Gonorrhea Therapeutics has experienced significant growth recently. It was projected to expand from $1.88 billion in 2024 to $1.98 billion in 2025, with a compound annual growth rate (CAGR) of 5.4%.
The 2029 market projections for the Gonorrhea Therapeutics Global Market report an expected size of $2.42 billion. This includes a forecasted growth rate of 5.2% CAGR.
Download Your Free Sample of the 2025 Gonorrhea Therapeutics Market Report and Uncover Key Trends Now!The key drivers in the gonorrhea therapeutics market are:
• Rising occurrences of sexually transmitted infections
• Increasing focus on personalized medicine
• Growth of antibiotic resistance patterns
• Growing demand for effective treatment methods
The gonorrhea therapeutics market covered in this report is segmented –
1) By Therapeutic Class: Antibiotics, Combination Therapy, Monotherapy
2) By Route Of Administration: Oral, Intravenous, Intramuscular
3) By Age Group: Pediatric, Adult, Geriatric
4) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies
5) By End User: Hospitals, Clinics, Home Care
Subsegments:
1) By Antibiotics: Beta-lactams, Macrolides, Fluoroquinolones, Aminoglycosides
2) By Combination Therapy: Dual Antibiotic Therapy, Triple Antibiotic Therapy
3) By Monotherapy: Single Antibiotic Treatment, Other Monotherapy Options
The key trends in the gonorrhea therapeutics market are:
• Technological developments are set to shape the future of the Gonorrhea therapeutics market.
• Advanced diagnostic tests are becoming an increasingly prevalent trend in this sector.
• The development of new therapeutics is a rising trend in the global market.
• The use of combination therapies and regulatory support for quick drug approvals is emerging as a key trend.
Major players in the gonorrhea therapeutics market are:
• Pfizer Inc.
• F. Hoffmann-La Roche Ltd
• Thermo Fisher Scientific Inc.
• Abbott Laboratories
• GlaxoSmithKline plc
• Becton Dickinson and Company
• Hologic Inc.
• Aurobindo Pharma Limited
• Innoviva Inc.
• Debiopharm Group
• Achilles Vaccines S.r.l.
• Melinta Therapeutics LLC
• VenatoRx Pharmaceuticals Inc.
• Evofem Biosciences Inc.
• Recce Pharmaceuticals Ltd.
• Therapyx Inc.
• Entasis Therapeutics Inc.
• Apotex Inc.
• Alopexx Pharmaceuticals LLC
• Summit Therapeutics Inc.
North America was the largest region in the gonorrhea therapeutics market in 2024